Clinical Trials
25 trialsSTRASS2
European Organisation for Research and Treatment of Cancer - EORTC
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
National Cancer Institute (NCI)
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
STORM Therapeutics LTD
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Polaris Group
ANTARES
Instituto do Cancer do Estado de São Paulo
A Study of Ivonescimab in People With Leiomyosarcoma
Memorial Sloan Kettering Cancer Center
APROMISS
Advenchen Laboratories, LLC
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
M.D. Anderson Cancer Center
PANTHR-S
Royal Marsden NHS Foundation Trust
REGOSTA
Centre Leon Berard
Localized Leiomyosarcoma Biomarker Protocol
University of Michigan Rogel Cancer Center
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
University of Colorado, Denver
PROSARC-1
Oslo University Hospital
PROSARC-2
Oslo University Hospital
XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
Northwestern University
TAIS
Fudan University
Metastatic Leiomyosarcoma Biomarker Protocol
University of Michigan Rogel Cancer Center
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Ohio State University Comprehensive Cancer Center
AOH1996 for the Treatment of Refractory Solid Tumors
City of Hope Medical Center
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
University of Utah
CoRDS
Sanford Health
TAGGED
Sarcoma Oncology Research Center, LLC
TRASTS
Grupo Espanol de Investigacion en Sarcomas